Muscular Dystrophy Type 2 · Limb-Girdle Muscular Dystrophy · LGMD · Sarcoglycanopathy · Gürtelmuskeldystrophie · Muskeldystrophie Typ 2 · Limb-girdle muscular dystrophy type 2C · LGMD2C · Gamma-sarcoglycanopathy · Sarcoglycan-deficient muscular dystrophy · Gliedergürtelmuskeldystrophie Typ R3 · Limb-girdle muscular dystrophy type 2F · LGMD2F · Delta-sarcoglycan deficiency · Gürtelmuskeldystrophie Typ R6 · SGCD-associated muscular dystrophy · LGMDR3 · LGMDR6 · Muscular dystrophy, limb-girdle, type R3 · Muscular dystrophy, limb-girdle, type R6
Muscular Dystrophy 2 is an inherited genetic disorder that affects the skeletal muscles, specifically covering the subtypes LGMDR3 and LGMDR6. It is caused by a deficiency in essential structural proteins that normally protect muscle fibers from damage during movement. Without these proteins, the muscle cells gradually break down and degenerate over time.
Owners typically notice symptoms in puppies or young adults, starting with a stiff, awkward gait and rapid fatigue during exercise. As the disease progresses, dogs develop visible muscle wasting and may experience difficulty swallowing.
There is no cure for this progressive condition, so treatment focuses on lifelong supportive care to manage symptoms and maintain comfort. Managing this disease typically costs between €1,500 and €6,000 over the dog's lifetime.
Estimated range of typical treatment cost. Actual cost depends on severity, clinic and region.
More conditions affecting the General / metabolic.